Acute and prophylactic treatments for migraine: present and future-Reference-Cited by-同舟云学术

Acute and prophylactic treatments for migraine: present and future

Published:2008-05 Issue:S1 Volume:29 Page:110-122
ISSN:1590-1874
Container-title:Neurological Sciences
language:en
Short-container-title:Neurol Sci

Author:

Rapoport Alan M.

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Clinical Neurology,Dermatology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10072-008-0901-x.pdf

Reference36 articles.

1. Cady RK (2001) Treatment strategies for migraine headache. JAMA 285:1014–1015

2. Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine — current understanding and treatment. N Engl J Med 346:257–270

3. Matchar DB, Young WB, Rosenberg JH et al (2000) Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management of acute attacks. www.neurology.org. April

4. Mathew NT, Kailasam J, Fischer A (2001) Early intervention using rofecoxib alone, rizatriptan alone and combination of rizatriptan and rofecoxib in acute migraine. Cephalalgia 21:405–432

5. Hawkey CJ (1999) COX-2 inhibitors. Lancet 353:307–314

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Pain and Headache After Traumatic Brain Injury;Physical Medicine and Rehabilitation Clinics of North America;2024-08

2. Alopecia signals associated with calcitonin gene‐related peptide inhibitors in the treatment or prophylaxis of migraine: A pharmacovigilance study;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-08-17

3. Treatment;Migraine in Medicine;2022

4. The efficacy and safety of antiepileptics in the prophylaxis of pediatric migraine: the meta-analysis of randomized controlled trials;Translational Pediatrics;2021-07

5. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Preventative Treatment of Episodic Migraine in Adults;Current Pain and Headache Reports;2019-09-12